Skip to main content

rfxcel extends Serialization & Traceability Compliance Solutions For Pharma

rfxcel (news@rfxcel.com), part of the Antares Vision Group, continues to extend its global pharmaceutical software serialization & compliance solutions for supply chain management.

—

The company, a global leader in serialization, continues to extend its global pharmaceutical enterprise solutions for end-to-end traceability, environmental monitoring, and regulatory compliance. As the industry experiences a large global digital supply chain transformation, rfxcel, a division of Antares Vision Group, provides cloud-based and scalable serialization software solutions, designed in accordance with the internationally accepted GAMP5, ISO90001, ISO27001, 21CFR Part 11, EU Annex11, and GS1 standards.

An example can be found at https://rfxcel.com/uzbekistan-pharma-serialization

The expert team at rfxcel now works with thousands of trading partners worldwide and recognizes the individual needs of each member in the trading partner ecosystem - enabling them to untangle the confusing maze of serialization standards and implement effective program solutions. Furthermore, rfxcel, which maintains offices in countries around the world and works closely with all global government agencies, now ensures that clients will be compliant no matter where they do business.

The global compliance and traceability solutions market is growing at over 13% annually - a trend that is expected to continue through the decade, due to the spike in demand for traceability solutions from various industries - especially the food and pharma sectors. Recent improvements in compliance and traceability systems, such as real-time monitoring and RFID technology, have contributed to market growth.

Since the global supply chain market requires absolute traceability, organizations that deploy supply chain visibility solutions enjoy improved efficiencies, save money, and can adapt swiftly to meet new market demands. rfxcel Supply Chain Visibility Software provides end-to-end visibility of product supply chains - from the use of ingredients in the manufacturing process to the distribution of the final product to the end consumer.

Additionally, meeting global pharmaceutical compliance requirements typically necessitates a significant investment and a shift in business processes. While companies need to use that investment to protect the supply chain from theft, diversion, and counterfeiting, rfxcel helps them use that software solution to gain additional insights that will yield a more productive and efficient supply chain.

By continuously monitoring incoming data, rfxcel helps clients to capture and leverage quality data for better business intelligence - resulting in better business outcomes and lower supply chain costs for their customers.

Another example can be seen at https://rfxcel.com/uae-pharmaceutical-products-traceability

Countries' laws for ensuring patient safety and combating the entry of counterfeit drugs into the supply chain vary greatly, adding many layers of complexity for pharmaceutical manufacturers, distributors, and retailers. This makes it especially important that pharmaceutical companies partner with a company that understands global compliance requirements.

One partner commented: “We have been a strategic partner with rfxcel since 2015. They have been outstanding in all of our interactions with them. Stable platform and great business team.”

Interested parties can learn more at https://rfxcel.com/solutions/pharmaceutical-compliance

Contact Info:
Name: Garrison Spik
Email: Send Email
Organization: rfxcel - Part of the Antares Vision Group
Address: 5385 Reno Corporate Drive, STE 200, Reno, NV NV 89511, United States
Website: https://rfxcel.com/

Source: PressCable

Release ID: 89089945

If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.